Postmarketing safety surveillance of 177Lu-DOTA-TATE (LUTATHERA): an observational, pharmacovigilance study leveraging FAERS database
This study enhances understanding of LUTATHERA's safety profile, offers clinicians valuable data, and advocates continuous pharmacovigilance. Continuous pharmacovigilance and potential label updates are recommended.
Authors
- Jing Liao (ORCID: https://orcid.org/0000-0002-4706-631X)
- Xinhua Wu (ORCID: https://orcid.org/0000-0003-4625-9635)
- Wei Chen (ORCID: https://orcid.org/0009-0007-4260-1794)
- Jianwei Dou
Institutions
- Union Hospital (HK)
- Huazhong University of Science and Technology (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1097/mnm.0000000000002015
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31